Antibiotic Resistance 2013 The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Ginger Beef Corporation

Ginger Beef Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Ginger Beef Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication | Countries: Canada

Yunnan Baiyao Group Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Yunnan Baiyao Group Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Drug and Medication | Countries: China

Tibet Cheezheng Tibetan Medicine Co Ltd

Tibet Cheezheng Tibetan Medicine Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Tibet Cheezheng Tibetan Medicine Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Drug and Medication

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 102 pages

BMI View: Despite the threat of austerity measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the patent cliff, we expect Switzerland to remain attractive to innovative drugmakers. Furthermore, ...

Industries: Drug and Medication | Countries: Switzerland

Qatar Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Qatar Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 105 pages

BMI View: Competition is gradually being introduced to Qatar’s pharmaceutical segment, creating opportunities for private segment development in the small but attractive industry . The pharmaceutical segment has seen temporary price rises following deregulation of imports. However, in the longer term ...

Industries: Drug and Medication | Countries: Qatar

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 119 pages

BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending reflects the UK government's focus on containing costs within the healthcare sector, and in particula ...

Industries: Drug and Medication | Countries: United Kingdom

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 110 pages

BMI View: While the depreciation of the local tender will negatively impact industry growth in US dollar terms, the roll-out of the insurance scheme and the elevated inflation will continue to push up local currency valuations. We envisage that the industry will experience a compound annual growth rate ...

Industries: Drug and Medication | Countries: Morocco

Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 122 pages

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to a rise d number of public-private partnerships (PPPs), which should deliver both efficiency savings and better healthcare outcomes. The country already has one of the most ...

Industries: Drug and Medication | Countries: Kuwait

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 132 pages

BMI View: While Venezuela’s distortive policies have damaged the country’s attractiveness for the last twelve years, President Hugo Chavez's taking ill has raised questions about the country’s future policy trajectory. Already home to one of Latin America's most unattractive business environments, ...

Industries: Drug and Medication | Countries: Venezuela

Adacel Technologies Ltd

Adacel Technologies Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Adacel Technologies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.